DDX11 gene

Early signs often include failure to thrive, significant growth retardation, and distinctive facial features such as a prominent forehead and deep-set eyes. Unlike many other genetic growth disorders, Warsaw breakage syndrome is frequently accompanied by specific congenital heart defects and hearing loss. A key diagnostic clue is the presence of chromosomal breakage in blood cells when exposed to certain chemicals, which reflects the underlying DNA repair defect caused by the DDX11 mutation. How does the DDX11 mutation affect DNA repair, and why does this lead to the physical abnormalities seen in the syndrome?::The DDX11 gene produces the ChlR1 enzyme, a helicase that unwinds DNA for replication and repair. Mutations in this gene result in a loss of ChlR1 function, causing the cell to fail in repairing DNA damage that occurs during cell division. This leads to an accumulation of DNA breaks, which triggers cell death or improper division. The widespread impact on cell turnover affects rapidly growing tissues such as bone, heart, and hearing structures, resulting in the characteristic physical malformations and growth impairments. Is Warsaw breakage syndrome a progressive condition, and what is the long-term prognosis for affected individuals?::The condition is generally considered non-progressive in terms of new structural defects, but the severity of symptoms can vary. Many individuals experience significant developmental delays and intellectual disability. The primary long-term health concerns are related to the initial congenital anomalies, such as heart defects which may require surgical intervention, and hearing loss which may necessitate hearing aids or cochlear implants. Life expectancy can be normal, but quality of life is often impacted by the need for ongoing medical and developmental support. What genetic testing is required to confirm a diagnosis of Warsaw breakage syndrome, and can parents be tested?::Diagnosis is confirmed through molecular genetic testing that identifies pathogenic variants in the DDX11 gene. This is often preceded by a chromosomal breakage test, which involves culturing blood cells and exposing them to a specific agent to observe characteristic DNA breaks. If a child is diagnosed, parents can undergo carrier testing to determine if they each carry one copy of the mutation. This information is vital for genetic counseling regarding the 25% recurrence risk for future pregnancies.